Area of research
Molecular Biology · Biomaterials
Research interest
Research interests include Lipid Membrane Structure and Behavior, RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, and Nanoparticle-Based Drug Delivery.
NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines
Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the <scp>NCI</scp>'S Nanotechnology Characterization Laboratory Service to the Research Community
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
Exploring Mechanisms of Lipid Nanoparticle‐Mucus Interactions in Healthy and Cystic Fibrosis Conditions
Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe <i>In Situ</i> Gene Editing in Human Skin
Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective
The current landscape of nucleic acid therapeutics
Optimized Photoactivatable Lipid Nanoparticles Enable Red Light Triggered Drug Release
PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
On the role of helper lipids in lipid nanoparticle formulations of siRNA
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Lipid Nanoparticle Systems for Enabling Gene Therapies
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
Liposomal drug delivery systems: From concept to clinical applications
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells